Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06089109 · ClinicalTrials.gov registry record · NA
Creating VIP Corps to Reduce Maternal Deaths
A NA study of Maternal Morbidity and Mortality, sponsored by Ann Coker.
- Recruiting
- Registry status
- NA
- Development phase
- 2,800
- Enrollment target
- 1
- Study location
NCT06089109: Recruiting NA study of Maternal Morbidity and Mortality, sponsored by Ann Coker.
NCT06089109 is a NA study of Maternal Morbidity and Mortality that is actively recruiting participants, run by Ann Coker. The registered enrollment target is 2,800 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06089109, a NA study of Maternal Morbidity and Mortality, is actively recruiting participants, sponsored by Ann Coker.
- RECRUITING
- Registry status
- NA
- Development phase
- 2,800 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to create and rigorously evaluate a violence intervention and prevention corps (VIP Corps) training using a randomized controlled trial among undergraduate and professional students; and to develop a novel maternal injury surveillance system (MISS) to complement an existing maternal violent death registry in Kentucky.
Primary Outcome
Change in knowledge of intimate partner violence (IPV) and attitudes toward those experiencing IPV by condition over time. Knowledge of pregnancy-associated causes of maternal mortality and morbidity created for this randomized controlled trial (RCT). This is a 17-item scale ranging from 0-35 with higher scores indicating greater (accurate) knowledge.
Conditions Studied
Interventions
- BEHAVIORAL The Big 3
- BEHAVIORAL Implementation and Effectiveness of VIP Corps Training
Study Locations (1)
Kentucky
- University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,800 participants |
| Start Date | 2023-09-25 |
| Est. Completion | 2027-09-29 |
| Phase | NA |
What NCT06089109 shows while recruiting
NCT06089109 is an interventional study that assigns participants to a tested intervention. Its 2,800 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% higher).
The record links to 1 condition, with Maternal Morbidity and Mortality appearing as the primary indexed condition, and to 2 interventions - of which The Big 3 is the first listed.
NCT06089109 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT06089109 about?
NCT06089109 is a clinical study titled "Creating VIP Corps to Reduce Maternal Deaths". The goal of this observational study is to create and rigorously evaluate a violence intervention and prevention corps (VIP Corps) training using a randomized controlled trial among undergraduate and professional students; and to develop a novel maternal injury surveillance system (MISS) to compleme...
What is the current status of trial NCT06089109?
This trial is currently recruiting. It is a NA study. The enrollment target is 2,800 participants. The study started on 2023-09-25. Estimated completion is 2027-09-29.
What conditions does trial NCT06089109 study?
This clinical trial studies the following conditions: Maternal Morbidity and Mortality.
What interventions are being tested in trial NCT06089109?
The interventions under investigation include: The Big 3 (BEHAVIORAL), Implementation and Effectiveness of VIP Corps Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT06089109?
This trial is sponsored by Ann Coker, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06089109 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06089109's enrollment target sits among peer trials
2,800 43rd of 2000 higher than 1,957 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05443737 · 2,800 participants · Phase 3
Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients
- NCT05899439 · 2,800 participants
Immune Function and the Progression to T1D
- NCT06345339 · 2,800 participants · Phase 2
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
- NCT06788093 · 2,800 participants · NA
Reducing Overuse of Antibiotics With Decision Support
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI